Gastric Content Ultrasound Monitoring Prior to Extubation in Critically Ill Children
Launched by HOSPICES CIVILS DE LYON · Dec 20, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to safely determine when critically ill children can be taken off a breathing tube, also known as extubation. The researchers want to figure out if using ultrasound to check the contents of a child's stomach can help avoid risks like vomiting and aspiration (when food or liquid goes into the lungs) during this process. Current guidelines suggest keeping the stomach empty before extubation, but critically ill children may not follow the same patterns as those who have had planned surgeries, which could lead to unnecessary waiting times or increased risks.
The trial is looking for children aged 0 to 17 who are currently in a pediatric intensive care unit, are intubated, and are receiving a significant portion of their nutrition through a feeding tube. If you participate, your child may undergo a simple ultrasound to check their stomach contents before the breathing tube is removed. This study aims to improve safety during the extubation process by better understanding how quickly children in critical care clear their stomachs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 0 to 17 year old children admitted to pediatric intensive care unit
- • intubated (oral or nasal tracheal tube)
- • gastric enteral feeding affording at least 25% of the nutritional target (estimated with Schofield equations)
- • No opposition from one of the 2 parents (or legal representatives)
- Exclusion Criteria:
- • anatomical anomaly of the stomach location (e.g. post surgery)
- • Difficult access to perform gastric ultra-sounding (drains, plasters, dressings etc.)
- • mobilization to right lateral decubitus at risk
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bron, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials